Showing 1881-1890 of 2216 results for "".
- PatientFi and The Aesthetic Society Form Alliance Partnershiphttps://modernaesthetics.com/news/patientfi-and-the-aesthetic-society-form-alliance-partnership/2473220/The Aesthetic Society and PatientFi entered into an Alliance Partnership to benefit members. PatientFi offers financing solution to help more patients afford the treatments and procedures they want, which, in turn, helps providers grow their case vol
- Study: Sick Patients Get Cosmetic Surgery to Look Healthierhttps://modernaesthetics.com/news/study-sick-patients-get-cosmetic-surgery-to-look-healthier/2473216/Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier, reports a small new Northwestern Medicine study. The patients believe cosmetic surgery may help them feel better in social situations with their friends, family or when they’re at work. &n
- PatientFi, Allergan Expand Co-marketing Agreementhttps://modernaesthetics.com/news/patientfi-allergan-expand-co-marketing-agreement/2473214/PatientFi® is expanding its co-marketing agreement with Allergan Aesthetics, an AbbVie company, to provide financing options for patients interested in treatments such as BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM®Collection of Fillers, Natrelle® breast i
- Aquavit's Neurotoxin Submitted to FDAhttps://modernaesthetics.com/news/aquavits-neurotoxin-submitted-to-fda/2473213/Aquavit Pharmaceuticals, Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the FDA for approval. The company also unveiled its development programs at the Annual meeting of the American Academy of Dermatology in Boston. DTX-021, a botulinum toxin type A drug intende
- New From Alma: Alma TED, CBD+ Professional Linehttps://modernaesthetics.com/news/new-from-alma-alma-ted-cbd-professional-line/2473212/Alma TED, an Ultrasound-based system with a propriety Tip engineered with Impact Delivery™, offers a non-invasive, non-traumatic option to address the market's growing hair loss concerns. Alma launched the device, along with the CBD+ Professional S
- Laser Surgery Lawsuits May be Less Likely with Physician Operatorshttps://modernaesthetics.com/news/laser-surgery-lawsuits-may-be-less-likely-with-physician-operators/2473208/The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician operator, according to a new study in the March 2022 issue of Dermatologic Surgery. Researchers analyzed cases of liability claims due to a cutaneou
- Newsweek OpEd: Senator, Modern Aesthetics® Magazine Contributor Address "No Surprises Act"https://modernaesthetics.com/news/newsweek-oped-senator-modern-aesthetics-magazine-contributor-address-no-surprises-act/2473207/Although surprise bills are one of the biggest drivers of medical bankruptcy in America, the "No Surprises Act" (NSA) is being overlooked, say Jonathan Kaplan, MD and Sen. William Cassidy, MD (R, Louisiana) in a new
- Endo Launches New Consumer Campaign for Qwohttps://modernaesthetics.com/news/endo-launches-new-consumer-campaign-for-qwo/2473202/Endo International plc is kicking off more than 200 patient events across the United States as part of Butt First, a new direct-to-consumer awareness campaign about Qwo (collagenase clostridium histolyticum-aaes). Qwo received FDA approval in Jul
- Leadership Changes Announced at SkinCeuticalshttps://modernaesthetics.com/news/leadership-changes-announced-at-skinceuticals/2473192/Stephanie Kramer is now SkinCeutical’s Global General Manager, and Amy Sloan is the Head of SkinCeuticals U.S, the company reports Sloan brings 15 years of global and U.S. beauty industry experience - 10 of those years with SkinCeuticals - to the role of Head o
- Avita Medical Inc. Shares Preclinical Data, Completes Enrollment in Pivotal Soft Tissue Reconstruction Trialhttps://modernaesthetics.com/news/avita-medical-inc-shares-preclinical-data-completes-enrollment-in-pivotal-soft-tissue-reconstruction-trial/2473181/Preclinical data successfully established proof of concept for Spray-On Skin™ Cells therapy from Avita Medical, Inc. in skin rejuvenation and epidermolysis bullosa, two key areas of cell-based gene therapy. Researchers at the Houston Methodist Research Institute (HMRI) partne